drugset / Trial / NCT03174067

Buprenorphine in the Emergency Department

NCT03174067

Phase 4 Completed 26 enrolled St. Joseph's Health Centre Toronto
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a pilot randomized control trial randomizing patients presenting in opioid withdrawal to the emergency department to receive either one of clonidine (usual standard of care) or buprenorphine for their opioid withdrawal. Primary treatment outcome is attendance at a rapid access addiction medicine clinic within a few days of emergency room presentation. Secondary treatment outcome is treatment status with respect to opioid agonist treatment at one month post emergency room visit.

Timeline

Start
2013-03
Primary completion
2016-04
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified
Comparator Clonidine Other / unclassified